DE69720469D1 - Nuklein-säuren die mit einem texaphyrin-metallkomplex intern derivatsiert sind und ihre verwendungen - Google Patents

Nuklein-säuren die mit einem texaphyrin-metallkomplex intern derivatsiert sind und ihre verwendungen

Info

Publication number
DE69720469D1
DE69720469D1 DE69720469T DE69720469T DE69720469D1 DE 69720469 D1 DE69720469 D1 DE 69720469D1 DE 69720469 T DE69720469 T DE 69720469T DE 69720469 T DE69720469 T DE 69720469T DE 69720469 D1 DE69720469 D1 DE 69720469D1
Authority
DE
Germany
Prior art keywords
metal complex
conjugates
texaphyrine
derivatively
derivatized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69720469T
Other languages
English (en)
Other versions
DE69720469T2 (de
Inventor
Darren Magda
P Crofts
Meredith Wright
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacyclics LLC
Original Assignee
Pharmacyclics LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacyclics LLC filed Critical Pharmacyclics LLC
Application granted granted Critical
Publication of DE69720469D1 publication Critical patent/DE69720469D1/de
Publication of DE69720469T2 publication Critical patent/DE69720469T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C12N2310/321—2'-O-R Modification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/35—Nature of the modification
    • C12N2310/351—Conjugate
    • C12N2310/3511—Conjugate intercalating or cleaving agent

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69720469T 1996-08-20 1997-08-20 Nuklein-säuren die mit einem texaphyrin-metallkomplex intern derivatsiert sind und ihre verwendungen Expired - Fee Related DE69720469T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US700277 1991-05-15
US70027796A 1996-08-20 1996-08-20
PCT/US1997/014682 WO1998007733A1 (en) 1996-08-20 1997-08-20 Nucleic acids internally-derivatized with a texaphyrin metal complex and uses thereof

Publications (2)

Publication Number Publication Date
DE69720469D1 true DE69720469D1 (de) 2003-05-08
DE69720469T2 DE69720469T2 (de) 2004-05-06

Family

ID=24812897

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69720469T Expired - Fee Related DE69720469T2 (de) 1996-08-20 1997-08-20 Nuklein-säuren die mit einem texaphyrin-metallkomplex intern derivatsiert sind und ihre verwendungen

Country Status (7)

Country Link
EP (1) EP0920439B1 (de)
JP (1) JP2000516631A (de)
AT (1) ATE236190T1 (de)
AU (1) AU4232597A (de)
CA (1) CA2263137A1 (de)
DE (1) DE69720469T2 (de)
WO (1) WO1998007733A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6022959A (en) * 1996-08-20 2000-02-08 Pharmacyclics, Inc. Nucleic acids internally-derivatized with a texaphyrin metal complex and uses thereof
US7112671B2 (en) 2000-08-30 2006-09-26 Pharmacyclics, Inc. Non-symmetric tripyrranes in the synthesis of novel macrocycles
US6638924B2 (en) 2000-08-30 2003-10-28 Pharmacyclics, Inc. Metallotexaphyrin derivatives
US7449454B2 (en) 2000-08-30 2008-11-11 Pharmacyclics, Inc. Metallotexaphyrin derivatives
US20070072838A1 (en) 2005-09-26 2007-03-29 Pharmacyclics, Inc. High-purity texaphyrin metal complexes
EP2013344B1 (de) * 2006-05-03 2012-08-29 Baltic Technology Development, Ltd. Antisense-agentien mit kombination von mit stark gebundener base modifiziertem oligonukleotid und künstlicher nuklease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5607924A (en) * 1992-01-21 1997-03-04 Pharmacyclics, Inc. DNA photocleavage using texaphyrins
EP0778845A1 (de) * 1994-09-02 1997-06-18 Novartis AG Oligonukleotidkonjugate, zusammensetzungen und verfahren zur spaltung von ribonukleinsäuren

Also Published As

Publication number Publication date
EP0920439A1 (de) 1999-06-09
ATE236190T1 (de) 2003-04-15
AU4232597A (en) 1998-03-06
CA2263137A1 (en) 1998-02-26
DE69720469T2 (de) 2004-05-06
EP0920439B1 (de) 2003-04-02
JP2000516631A (ja) 2000-12-12
WO1998007733A1 (en) 1998-02-26

Similar Documents

Publication Publication Date Title
CA2121658A1 (en) Internal Controls for Isothermal Nucleic Acid Amplification Reactions
HUP9901874A2 (hu) Humán TNFalfa-t kötő antitestek
ES2122692T3 (es) Procedimiento de amplificacion de acidos nucleicos en fase solida y equipo de reactivos para su realizacion.
EP0707638A4 (de) Regulierbare, therapeutische nukleinsäure und verfahren zur deren verwendung
WO1999016871A3 (en) Nucleic acid catalysts with endonuclease activity
BR9106440A (pt) Oligonucleotideo ou analogo de olifonucleotideo e processo para tratar um animal suspeito de ter uma doenca que se caracteriza pela expressao de gene tat de hiv
DE69521517D1 (de) Prodrug-oligonukleotide
DE69831224D1 (de) Immuntoxine, die ein onc protein enthalten, gegen bösartige zellen
DE69331946T2 (de) Nukleozyme
NO975313L (no) Hydrolyse og fotospaltning av nukleinsyre ved bruk av metallkompleks
WO1998043993A3 (en) Nucleic acid catalysts
DE69720469D1 (de) Nuklein-säuren die mit einem texaphyrin-metallkomplex intern derivatsiert sind und ihre verwendungen
FR2590591B1 (fr) Adnc codant pour la manganese-superoxyde-dismutase humaine, son expression dans des bacteries et procede pour recueillir de la manganese-superoxyde-dismutase humaine douee d'activite enzymatique.
DE69814857D1 (de) Verfahren zur etherifizierung von benzylalkoholen, erhaltene produkte und ihre verwendungen
DE69302369D1 (de) Erhöhung der katalytischen Aktivität von Ribozymen mit einem benachbartem Oligonukleotid als Heffer
NO970885L (no) Oligonukleotid konjugater, sammensetninger og fremgangsmåter for splitting av ribonukleotider
EA200100987A1 (ru) Реагенты, содержащие бороновые кислоты, и олигонуклеотиды
BE1001858A3 (nl) Werkwijze voor het raffineren van olien.
Wong BIOCHEMICAL AND IMMUNOLOGICAL STUDIES ON FAMILIAL ERYTHROPHAGOCYTIC LYMPHOHISTIOCYTOSIS.
Watts FIRST PREGNANCY: ITS IMPACT ON SEX ROLE ORIENTATION, CAREER ORIENTATION, AND BODY IMAGE.
Corbett Regulation of the catalytic cycle of topoisomerase II.
Kirkbride Factors influencing Maryland's Upper Eastern Shore farmers to implement best management practices: Focus on the effectiveness of the Indiantown Demonstration Farm educational program.
O'QUIN CONFORMITY AND HELPING BEHAVIOR: AN INFORMATION-WEIGHTING ANALYSIS.
Galloway AQUATIC NITROGEN CYCLING: THE PROCESSING OF NITRATE BY CHLORELLA VULGARIS AND THE POSSIBILITY OF AMMONIA LOSS TO THE ATMOSPHERE.
Hauenstein A comparative analysis of the underlying learning processes in behavior modeling: Social learning theory evaluated.

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee